Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
about
Circumventing antivector immunity: potential use of nonhuman adenoviral vectorsHemaMax™, a recombinant human interleukin-12, is a potent mitigator of acute radiation injury in mice and non-human primatesKey role for CD4 T cells during mixed antibody-mediated rejection of renal allografts.Regulation of the formyl peptide receptor 1 (FPR1) gene in primary human macrophagesInteraction between immunoglobulin allotypes and NK receptor genes in diabetes post-hepatitis C virus infectionType III IFNs are produced by and stimulate human plasmacytoid dendritic cells.Influence of signal transducer and activator of transcription-1 signaling on thyroid morphology and functionAge-dependent resistance to Porcine reproductive and respiratory syndrome virus replication in swine.Evaluation of clinical biomaterial surface effects on T lymphocyte activation.Agrobacterium sp.-derived β-1,3-glucan enhances natural killer cell activity in healthy adults: a randomized, double-blind, placebo-controlled, parallel-group study.Host defenses against bacterial lower respiratory tract infection.Human Pegivirus (HPgV; formerly known as GBV-C) inhibits IL-12 dependent natural killer cell function.Autocrine, not paracrine, interferon-gamma gene delivery enhances ex vivo antigen-specific cytotoxic T lymphocyte stimulation and killing.Humanized mice as a model for aberrant responses in human T cell immunotherapy.Down modulation of IFN-gamma signaling in alveolar macrophages isolated from smokers.Interferon-γ Reduces the Proliferation of Primed Human Renal Tubular Cells.Evaluation of immune responses induced by a novel human papillomavirus type 16 E7 peptide-based vaccine with Candida skin test reagent as an adjuvant in C57BL/6 mice.Interferon γ suppresses dentin sialophosphoprotein in oral squamous cell carcinoma cells resulting in antitumor effects, via modulation of the endoplasmic reticulum response
P2860
Q26995655-B8FEDC8E-1A23-4514-917E-52E0F9575D49Q28731776-D24D1AD1-DBC0-4852-BA8B-3475B4551041Q34024926-30DD420B-42A1-4EFB-985D-9C24B839CCE9Q34491175-27EBCD02-D93C-432A-AFBF-284A1073125AQ34949587-0CD7A35D-20A8-4BEE-BBD4-3B71A00ADBB0Q36630086-DD37ED8E-AC15-4D6E-8377-4199B46EAAF5Q37244622-892544BC-04B1-475F-AC38-5990973A6B28Q37413006-2EF092E1-D364-418E-85F9-52EBC438CAFAQ37456973-B2C83329-C8EA-4733-813C-30915FFB9C7AQ37634602-7D8D77C6-1BB9-4BED-ABE8-762560E9462EQ37677020-F393747E-1E21-4D52-9A28-165868E1BECFQ38846135-DCD2A966-3FF8-4ED2-B473-BDB561EB5168Q39701753-BEDD831E-1AF9-421B-BD47-EEF9060D299CQ41816196-616C3BF3-5EF1-4F14-93F9-7C607040262FQ41888499-6FF8D424-0D2C-486C-B620-74BD1EF2D061Q41977811-61FC9504-24F2-4104-BEEB-AE5FDE5D8E5AQ50134597-735CEBB6-8960-4E0D-9778-95CD8D7E8473Q57478301-3D5D5338-8613-4605-BF26-446934070768
P2860
Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
@ast
Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
@en
type
label
Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
@ast
Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
@en
prefLabel
Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
@ast
Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
@en
P2093
P1476
Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts)
@en
P2093
P304
P577
2006-07-01T00:00:00Z